# Analytical delivery completion assessment

17 October 2026, Asia/Manila. Accountable role: Data Analyst, with sequential
BI interpretation and documentation self-review. Prepared at the user's request
for percentage progress by descriptive, diagnostic, predictive and prescriptive
analytics. This is a **proposed planning rubric**, not an existing approved KPI,
an estimate of effort remaining, model accuracy, operational readiness or formal
completion of the original O1–O5 objectives. Evidence is inherited from cited
dated records; no fresh runtime/cloud/model test was executed for this assessment.

## Method and result

Each category has ten equally weighted checkpoints. A checkpoint earns one point
only when the specified bounded output has retained implementation/verification
evidence. An open or unverified checkpoint earns zero; prepared plans receive
no fractional credit. Passing a checkpoint establishes only its stated scope.
The grouping and equal weights are analyst judgment, proposed here for transparent
progress reporting. A different agreed scope or weighting can change the rates.
These categories mix software, analytical evidence and acceptance milestones;
they are not estimates of equal workload or independent statistical observations.

| Category | Evidenced checkpoints | Open checkpoints | Delivery completion |
|---|---:|---:|---:|
| Descriptive | 8/10 | 2 | 80% |
| Diagnostic | 7/10 | 3 | 70% |
| Predictive | 5/10 | 5 | 50% |
| Prescriptive | 3/10 | 7 | 30% |
| Overall, equal category weights | 23/40 | 17 | 57.5% |

Formula: completed checkpoints divided by defined checkpoints, multiplied by 100.
Overall: (80 + 70 + 50 + 30) / 4 = 57.5%. Display 58% only when explicitly
rounding to a whole percentage. Do not label 57.5% as official capstone acceptance.
No new scope amendment, review decision or publication approval is recorded.

## Descriptive checklist

| ID | Checkpoint and boundary | Score | Evidence or missing exit |
|---|---|---:|---|
| D1 | Deployment CSV lineage and candidate Gold financial reconciliation | 1 | [Nine-source verification](../outputs/source_verification_20261017/README.md): nine exports and fact20 identity/totals reconcile. This is historical-source reconciliation, not annual-upload turnover. |
| D2 | Eligible recorded net-sales summaries | 1 | Same source receipt and [integration](../outputs/analytics_system_completion_20261015/README.md). |
| D3 | Gross margin and same-population rate definitions checked | 1 | [Definitions](BUSINESS_DEFINITIONS.md) and [module evidence](../outputs/t09_modules_20261017/README.md). |
| D4 | Period/grain controls and observation coverage representation | 1 | [Descriptive logic](DESCRIPTIVE_ANALYTICS_LOGIC.md) and [graph clarity](../outputs/graph_clarity_20261017/README.md). |
| D5 | Recorded product contribution, Pareto and deterministic ABC | 1 | [Module evidence](../outputs/t09_modules_20261017/README.md). Source-label financial scope, candidate ABC policy. |
| D6 | Mapped-area and buyer summaries with explicit populations | 1 | Module evidence and graph clarity; derived mappings and unallocated amounts stay visible. |
| D7 | Source-bound displayed tables and CSV scope agreement | 1 | Module evidence and [QA repairs](../outputs/qa_remediation_20261017/README.md). |
| D8 | Null/zero/negative/partial and unavailable presentation safeguards | 1 | Graph clarity and QA repairs. |
| D9 | Independently substantiated reporting completeness and original physical quantity interpretation at required study grain | 0 | Adrian confirmed complete COO-provided recorded-sales submission. [Twenty-label research/review](../outputs/descriptive_closure_20261017/UNIT_REVIEW_DECISIONS.md) is complete, but does not supply independent historical unit verification; unknown months and adjusted provenance remain explicit. Original required-grain evidence or an actual scope amendment remains necessary. |
| D10 | Version-bound end-to-end descriptive scope and actual stakeholder/publication acceptance | 0 | [Fresh live fact20 check](../outputs/descriptive_closure_20261017/closure-recheck.json) passes Overview/API/product-category CSV/ledger reconciliation. [Review proposal](../outputs/descriptive_closure_20261017/START_HERE.md) is prepared; actual business/adviser acceptance and original territorial/frequency scope remain open. |

## Diagnostic checklist

| ID | Checkpoint and boundary | Score | Evidence or missing exit |
|---|---|---:|---|
| G1 | Matched calendar year-over-year comparisons with coverage rules | 1 | Descriptive logic, module evidence and graph clarity. |
| G2 | Adjacent observed full-month movement analysis | 1 | Descriptive logic and module evidence. |
| G3 | Signed change partitions reconcile across month/product/raw-area/buyer dimensions | 1 | [Investigation contract](DRILLDOWN_DIAGNOSTICS.md) and module evidence. |
| G4 | Selected contribution traces to exact dated source transaction lineage | 1 | Investigation contract and module evidence. |
| G5 | Version-matched company monthly STL for 2020–2025 | 1 | Integration and module evidence, including source-bound 72-row STL export. Does not prove promised territorial/daily decomposition. |
| G6 | Historical disease/weather/proxy context with separate provenance | 1 | [Architecture](ARCHITECTURE.md) and [API](API.md). Context display only, without accepted causal/external regression. |
| G7 | Exportable investigation evidence with explicit unverified cause labels | 1 | Investigation contract and exact-period investigation JSON in module evidence. |
| G8 | Accepted territory/time/product external joins and evaluated explanatory analysis | 0 | Original join gates remain open; context displays alone do not satisfy them. |
| G9 | Corroborated business-cause investigations | 0 | Stockout, disease, contract, pricing and comparable quantity explanations still need independent evidence. Contribution arithmetic is not causal identification. |
| G10 | Stakeholder-reviewed diagnostic findings for the required study scope | 0 | Actual scope/usefulness acceptance and outstanding original granularity remain open in the objective register. |

## Predictive checklist

| ID | Checkpoint and boundary | Score | Evidence or missing exit |
|---|---|---:|---|
| F1 | Frozen company monthly PHP input with source/cutoff provenance | 1 | [Findings](chapters/MedShield_Predictive_Findings_Update_20261015.md) and integration evidence. |
| F2 | Executed company-PHP baselines and model comparisons | 1 | Findings: original 21 configurations and six separate later exploratory recipes. |
| F3 | Retained time-ordered development and retrospective audit design | 1 | Findings; 60 development cases over 24 targets and 12 audit targets. Previously inspected audit limits remain. This earns design/execution credit, not untouched final-test acceptance. |
| F4 | Reproducible errors, bias and cumulative lead-group evidence | 1 | Findings and [historical error review](../outputs/t09_modules_20261017/step3-ERROR_REVIEW.md). |
| F5 | Stored research/projection UI and matching CSV with true leads and forecast YoY | 1 | Integration and [forecast YoY](../outputs/predictive_yoy_20261016/README.md). No measured 2026 projection error. |
| F6 | Verified medicine-unit/SKU/territory input series and evaluated quantity model | 0 | [Ordered plan](ANALYTICAL_COMPLETION_STEPS.md): historical unit/identity/coverage and actual pilot readiness still open. Offline adapter/bridge completion does not satisfy this checkpoint. |
| F7 | Accepted issue-time disease/weather predictors and evaluated external model | 0 | Join/feature/target gates remain open. |
| F8 | Original predictive classification/urgency targets and held-out evaluation | 0 | Objective register: original classifier designs and urgency truth/evaluation unresolved. Deterministic ABC is not an evaluated predictive classifier. |
| F9 | Accepted decision-relevant performance and credible prospective/untouched confirmation | 0 | Last-value retrospective audit WAPE 37.763644%; proposed 10% research goal unachieved, business tolerance unset and future accuracy unmeasured. |
| F10 | Governed approved model publication/activation for intended operational scope | 0 | Candidate research remains unpublished; actual approval is not supplied by a populated chart. |

## Prescriptive checklist

| ID | Checkpoint and boundary | Score | Evidence or missing exit |
|---|---|---:|---|
| P1 | Candidate commercial shortlist and historical sales ranking | 1 | Module evidence and descriptive logic. Current sales/coverage score does not establish outbreak urgency. |
| P2 | Explicit assumed-input allocation scenario with bounded feasibility checks | 1 | [Business definitions](BUSINESS_DEFINITIONS.md), API and module evidence. Greedy scenario, no global optimality claim. |
| P3 | Scenario acknowledgement, stale-source rejection and UI/CSV agreement | 1 | Module evidence, including an actual gateway scenario using synthetic QA assumptions. |
| P4 | Verified on-hand/on-order/commitment data in compatible product units | 0 | Original O4 operational-input gate remains open. Entered stock assumptions are not an inventory feed. |
| P5 | Verified supplier, lead-time and lot-expiry inputs | 0 | Ordered plan and objective register. |
| P6 | Reviewed operating costs, budget/capacity and service policy inputs | 0 | No full operational cost/constraint evidence; values entered for a scenario do not close this gate. |
| P7 | Integrated and validated EOQ/reorder-point outputs for accepted inputs | 0 | Objective register: active scenario allocation does not compute operational EOQ/ROP. |
| P8 | Accepted operational optimization objective and end-to-end optimality/constraint evidence | 0 | Active solver is bounded greedy; offline optimization code does not prove a deployed cost-optimal workflow. |
| P9 | Validated disease/urgency-aware prioritization and accepted demand dependency | 0 | Current commercial ranking, unknown medicine units and blocked external joins do not close original MCDA/urgency requirements. |
| P10 | Approved operational pilot with measured expiry/stockout/cost outcomes | 0 | Original expiry-wastage target remains unmeasured. Scenario completion is not procurement authority or measured benefit. |

## What to demonstrate as proof

| Category | Live local demonstration | Analytical-layer evidence to retain |
|---|---|---|
| Descriptive | Overview, Product and Area views using explicit dates; show net sales, 98/108 observation coverage, category/cohort filters and matching CSV | Source hashes and audit; Gold fact20 and monthly/yearly candidate views; selected API response, exact chart/table/export population and release identity. |
| Diagnostic | Sales Diagnostics matched YoY; select a change and open Change investigation; drill into product/area contributions and source rows; show STL and its separate full-history scope | Signed partitions sum to the same total difference; exact dated transaction lineage and investigation JSON; source-bound STL export. External context stays distinct from causes. |
| Predictive | Forecast Modeling, Stored predictive research: experiment/model/stage/leads; show historical errors and stored projections with prior-year YoY baseline | Matching stored experiment/frozen input in Gold, lead-keyed rows and CSV. State last-value full audit WAPE 37.76%, and distinguish it from the separate seasonal-naive benchmark at 72.89%. |
| Prescriptive | Prescriptive Planning: current shortlist, entered assumptions, acknowledgement, feasible allocation, infeasible-budget response and CSV | Selected Gold inputs plus explicitly assumed stock/demand/cost values, constraints and scenario result. Say scenario-only; do not claim an approved purchase or real EOQ/ROP. |

Databricks proves lineage, contracts and stored evidence; the gateway and dashboard
prove that users can obtain the correct selected representation. A screenshot alone
does not establish numerical correctness. Use the actual retained receipts, then
capture a matched current demonstration rather than calling this assessment a new
live validation. The [presentation/guide packet](../outputs/analytics_progress_20261017/README.md)
supplies supporting material; this assessment does not silently revise its files.

## Remaining work and use of the percentages

Highest priority dependencies: source/catalog owner substantiates historical units,
identity and completeness; analyst/model owner defines eligible target series and
time-ordered tests; operations owner supplies verified stock, supplier, lead-time,
expiry and cost inputs. Project lead/client/adviser records the exact permitted
reporting and original-scope acceptance separately.

Suggested presentation wording: “Using our 40-checkpoint analytical delivery
assessment dated 17 October, we have completed 23 checkpoints, or 57.5% overall.
Descriptive is 80%, diagnostic 70%, predictive 50% and prescriptive 30%. Our strongest
evidence is recorded-sales reporting and change investigation. Forecasts remain
company-revenue research, and planning remains scenario-based.”

Verification for this assessment: 40 unique binary checkpoints, category totals,
overall arithmetic and local source links checked by a retained script under
`outputs/analytics_completion_20261017/`. Inherited evidence was reviewed; model,
warehouse and app checks were not rerun. No application/data/model/schema/server
or acceptance change. Applied skills: analytics frameworks for explicit metrics
and claim boundaries; database standards for lineage/joins; business-analysis
frameworks for target scope; documentation standards for dated traceability.
